価格表

在庫・価格 : 2024年05月18日 10時15分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Fetuin-A, Human, ELISA Kit (96well)
データシート
RD191037100 BLMバイオベンダー ラボラトリー
BioVendor Laboratory Medicine, Inc.
1 kit ¥108,000
(未発注)
追加

在庫・価格 : 2024年05月18日 10時15分 現在

Fetuin-A, Human, ELISA Kit (96well)

  • 商品コード:RD191037100
  • メーカー:BLM
  • 包装:1kit
  • 価格: ¥108,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Mori K et al. Association of serum fetuin-A with insulin resistance in type 2 diabetic and nondiabetic subjects. Diabetes Care 2006 Feb;29(2):468
Mori K et al
2006/01/01
Species: Human, Applications: Serum,Plasma PubMed
2 Jung HH et al. Inflammation, mineral metabolism and progressive coronary artery calcification in patients on haemodialysis. Nephrol. Dial. Transplant. 2006 Jul;21(7):1915-20
Jung HH et al
2006/01/01
Species: Human, Applications: Serum,Plasma PubMed
3 Stefan N et al. Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care 2006 Apr;29(4):853-7
Stefan N et al
2006/01/01
Species: Human, Applications: Serum,Plasma PubMed
4 ZiテウナLowska H et al. [Fetuin A in children with renal diseases]. Prz. Lek. 2006;63 Suppl 3:54-6
ZiテウナLowska H et al
2006/01/01
Species: Human, Applications: Serum,Plasma PubMed
5 Mori K et al. Association of serum fetuin-A with carotid arterial stiffness. Clin. Endocrinol. (Oxf) 2007 Feb;66(2):246-50
Mori K et al
2007/01/01
Species: Human, Applications: Serum,Plasma PubMed
6 Caglar K et al. Endothelial dysfunction and fetuin A levels before and after kidney transplantation. Transplantation 2007 Feb;83(4):392-7
Caglar K et al
2007/01/01
Species: Human, Applications: Serum,Plasma PubMed
7 Kaden JJ et al. Systemic and local levels of fetuin-A in calcific aortic valve stenosis. Int. J. Mol. Med. 2007 Aug;20(2):193-7
Kaden JJ et al
2007/01/01
PubMed
8 Eller P et al. Impact of ENPP1 genotype on arterial calcification in patients with end-stage renal failure. Nephrol. Dial. Transplant. 2008 Jan;23(1):321-7
Eller P et al
2008/01/01
PubMed
9 Sigrist MK et al. Progressive vascular calcification over 2 years is associated with arterial stiffening and increased mortality in patients with stages 4 and 5 chronic kidney disease. Clin J Am Soc Nephrol 2007 Nov;2(6):1241-8
Sigrist MK et al
2007/01/01
PubMed
10 Caglar K et al. Short-term treatment with sevelamer increases serum fetuin-a concentration and improves endothelial dysfunction in chronic kidney disease stage 4 patients. Clin J Am Soc Nephrol 2008 Jan;3(1):61-8
Caglar K et al
2008/01/01
PubMed
11 Oikawa O et al. Evaluation of serum fetuin-A relationships with biochemical parameters in patients on hemodialysis. Clin. Exp. Nephrol. 2007 Dec;11(4):304-8
Oikawa O et al
2007/01/01
PubMed
12 Yilmaz MI et al. Endothelial dysfunction in type-2 diabetics with early diabetic nephropathy is associated with low circulating adiponectin. Nephrol. Dial. Transplant. 2008 May;23(5):1621-7
Yilmaz MI et al
2008/01/01
PubMed
13 Stejskal D et al. Urine fetuin-A values in relation to the presence of urolithiasis. BJU Int. 2008 May;101(9):1151-4
Stejskal D et al
2008/01/01
Species: Human, Applications: Serum,Plasma PubMed
14 Ziolkowska H et al. Determinants of the intima-media thickness in children and adolescents with chronic kidney disease. Pediatr. Nephrol. 2008 May;23(5):805-11
Ziolkowska H et al
2008/01/01
PubMed
15 Petrik V et al. Serum alpha 2-HS glycoprotein predicts survival in patients with glioblastoma. Clin. Chem. 2008 Apr;54(4):713-22
Petrik V et al
2008/01/01
PubMed
16 Caglar K et al. Serum fetuin-a concentration and endothelial dysfunction in chronic kidney disease. Nephron Clin Pract 2008;108(3):c233-40
Caglar K et al
2008/01/01
PubMed
17 Hennige AM et al. Fetuin-A induces cytokine expression and suppresses adiponectin production. PLoS ONE 2008;3(3):e1765
Hennige AM et al
2008/01/01
Species: Human, Applications: Serum,Plasma PubMed
18 Stefan N et al. Plasma fetuin-A levels and the risk of type 2 diabetes. Diabetes 2008 Oct;57(10):2762-7
Stefan N et al
2008/01/01
Species: Human, Applications: Serum,Plasma PubMed
19 Reinehr T et al. Fetuin-A and its relation to metabolic syndrome and fatty liver disease in obese children before and after weight loss. J. Clin. Endocrinol. Metab. 2008 Nov;93(11):4479-85
Reinehr T et al
2008/01/01
Species: Human, Applications: Serum,Plasma PubMed
20 Dervisoglu E et al. Serum fetuin--a concentrations are inversely related to cytokine concentrations in patients with chronic renal failure. Cytokine 2008 Dec;44(3):323-7
Dervisoglu E et al
2008/01/01
PubMed
21 Pańczyk-Tomaszewska M et al. [Fetuin A in children with nephrotic syndrome]. Pol. Merkur. Lekarski 2008;24 Suppl 4:65-7
Pańczyk-Tomaszewska M et al
2008/01/01
PubMed
22 Weikert C et al. Plasma fetuin-a levels and the risk of myocardial infarction and ischemic stroke. Circulation 2008 Dec;118(24):2555-62
Weikert C et al
2008/01/01
Species: Human, Applications: Serum,Plasma PubMed
23 Briana DD et al. Serum fetuin-A/alpha2-HS-glycoprotein in human pregnancies with normal and restricted fetal growth. J. Matern. Fetal. Neonatal. Med. 2008 Nov;21(11):826-30
Briana DD et al
2008/01/01
PubMed
24 Roos M et al. Fetuin-A and arterial stiffness in patients with normal kidney function. Regul. Pept. 2009 Apr;154(1-3):39-43
Roos M et al
2009/01/01
PubMed
25 Pertosa G et al. Serum fetuin a in hemodialysis: a link between derangement of calcium-phosphorus homeostasis and progression of atherosclerosis? Am. J. Kidney Dis. 2009 Mar;53(3):467-74
Pertosa G et al
2009/01/01
PubMed
26 Bl叩ha V et al. Circulating fetuin-A predicts early mortality in chronic hemodialysis patients. Clin. Biochem. 2009 Jul;42(10-11):996-1000
Bl叩ha V et al
2009/01/01
PubMed
27 Tumani H et al. CSF proteome analysis in clinically isolated syndrome (CIS): candidate markers for conversion to definite multiple sclerosis. Neurosci. Lett. 2009 Mar;452(2):214-7
Tumani H et al
2009/01/01
PubMed
28 Katayama H et al. Application of serum proteomics to the Women"s Health Initiative conjugated equine estrogens trial reveals a multitude of effects relevant to clinical findings. Genome Med 2009;1(4):47
Katayama H et al
2009/01/01
PubMed
29 Kaushik SV et al. Extended-release niacin decreases serum fetuin-A concentrations in individuals with metabolic syndrome. Diabetes Metab. Res. Rev. 2009 Jul;25(5):427-34
Kaushik SV et al
2009/01/01
PubMed
30 Sigrist MK et al. Elevated osteoprotegerin is associated with all-cause mortality in CKD stage 4 and 5 patients in addition to vascular calcification. Nephrol. Dial. Transplant. 2009 Oct;24(10):3157-62
Sigrist MK et al
2009/01/01
PubMed
31 Urbanov叩 M et al. Fetuin-A early after renal transplantation. Kidney Blood Press. Res. 2009;32(3):217-22
Urbanov叩 M et al
2009/01/01
PubMed
32 Cianciolo G et al. Coronary calcifications in end-stage renal disease patients: a new link between osteoprotegerin, diabetes and body mass index? Blood Purif. 2010;29(1):13-22
Cianciolo G et al
2010/01/01
PubMed
33 Brettschneider J et al. Proteome analysis reveals candidate markers of disease progression in amyotrophic lateral sclerosis (ALS). Neurosci. Lett. 2010 Jan;468(1):23-7
Brettschneider J et al
2010/01/01
PubMed
34 Emoto M et al. Fetuin-A and atherosclerotic calcified plaque in patients with type 2 diabetes mellitus. Metab. Clin. Exp. 2010 Jun;59(6):873-8
Emoto M et al
2010/01/01
PubMed
35 Uz O et al. The relationship between coronary calcification and the metabolic markers of osteopontin, fetuin-A, and visfatin. Turk Kardiyol Dern Ars 2009 Sep;37(6):397-402
Uz O et al
2009/01/01
PubMed
36 Ford ML et al. Fetuin-A is an independent determinant of change of aortic stiffness over 1 year in non-diabetic patients with CKD stages 3 and 4. Nephrol. Dial. Transplant. 2010 Jun;25(6):1853-8
Ford ML et al
2010/01/01
PubMed
37 Smith ER et al. Poor agreement between commercial ELISAs for plasma fetuin-A: An effect of protein glycosylation? Clin. Chim. Acta 2010 Sep;411(17-18):1367-70
Smith ER et al
2010/01/01
PubMed
38 Kl旦ting N et al. Insulin-sensitive obesity. Am. J. Physiol. Endocrinol. Metab. 2010 Sep;299(3):E506-15
Kl旦ting N et al
2010/01/01
PubMed
39 Kuナ嬾ierz-Cabala B et al. Serum fetuin A concentrations in patients with acute pancreatitis. Clin. Lab. 2010;56(5-6):191-5
Kuナ嬾ierz-Cabala B et al
2010/01/01
PubMed
40 Brix JM et al. Elevated Fetuin-A concentrations in morbid obesity decrease after dramatic weight loss. J. Clin. Endocrinol. Metab. 2010 Nov;95(11):4877-81
Brix JM et al
2010/01/01
PubMed
41 T旦njes A et al. Adipokine pattern in subjects with impaired fasting glucose and impaired glucose tolerance in comparison to normal glucose tolerance and diabetes. PLoS ONE 2010;5(11):e13911
T旦njes A et al
2010/01/01
PubMed
42 Cutler P et al. Proteomic identification and early validation of complement 1 inhibitor and pigment epithelium-derived factor: Two novel biomarkers of Alzheimer"s disease in human plasma. Proteomics Clin Appl 2008 Apr;2(4):467-77
Cutler P et al
2008/01/01
PubMed
43 Abali R et al. The serum protein α2-Heremans-Schmid glycoprotein/fetuin-a concentration and carotid intima-media thickness in women with polycystic ovary syndrome. Eur. J. Obstet. Gynecol. Reprod. Biol. 2013 Jul;169(1):45-9
Abali R et al
2013/01/01
PubMed
44 Aleksandrova K et al. Circulating Omentin as a Novel Biomarker for Colorectal Cancer Risk: Data from the EPIC-Potsdam Cohort Study. Cancer Res. 2016 07;76(13):3862-71
Aleksandrova K et al
2016/01/01
PubMed
45 Argani H et al. Serum Fetuin-A and Pentraxin3 in hemodialysis and renal transplant patients. Clin. Biochem. 2012 Jul;45(10-11):775-9
Argani H et al
2012/01/01
PubMed
46 Bakiner O et al. Plasma fetuin-A levels are reduced in patients with hypothyroidism. Eur. J. Endocrinol. 2014 Mar;170(3):411-8
Bakiner O et al
2014/01/01
PubMed
47 Cagli K et al. Association of serum fetuin-A with valvular calcium concentration in rheumatic mitral valve disease. J. Heart Valve Dis. 2010 Sep;19(5):636-43
Cagli K et al
2010/01/01
PubMed
48 Chang WT et al. Serum vitamin D, intact parathyroid hormone, and Fetuin A concentrations were associated with geriatric sarcopenia and cardiac hypertrophy. Sci Rep 2017 01;7:40996
Chang WT et al
2017/01/01
PubMed
49 Dalamaga M et al. Higher fetuin-A, lower adiponectin and free leptin levels mediate effects of excess body weight on insulin resistance and risk for myelodysplastic syndrome. Metab. Clin. Exp. 2013 Dec;62(12):1830-9
Dalamaga M et al
2013/01/01
PubMed
50 Eraso LH et al. Association of lower plasma fetuin-a levels with peripheral arterial disease in type 2 diabetes. Diabetes Care 2010 Feb;33(2):408-10
Eraso LH et al
2010/01/01
PubMed
51 Hamano T et al. Fetuin-mineral complex reflects extraosseous calcification stress in CKD. J. Am. Soc. Nephrol. 2010 Nov;21(11):1998-2007
Hamano T et al
2010/01/01
PubMed
52 Harris VK et al. Cerebrospinal fluid fetuin-A is a biomarker of active multiple sclerosis. Mult. Scler. 2013 Feb;
Harris VK et al
2013/01/01
PubMed
53 Hwang JJ et al. Circulating fetuin-A levels are not affected by short and long-term energy deprivation and/or by leptin administration. Metab. Clin. Exp. 2014 Jun;63(6):754-9
Hwang JJ et al
2014/01/01
PubMed
54 Ishibashi A et al. Serum fetuin-A is an independent marker of insulin resistance in Japanese men. J. Atheroscler. Thromb. 2010 Sep;17(9):925-33
Ishibashi A et al
2010/01/01
PubMed
55 Jim辿nez MC et al. Circulating fetuin-A and risk of ischemic stroke in women. Clin. Chem. 2014 Jan;60(1):165-73
Jim辿nez MC et al
2014/01/01
PubMed
56 Kaess BM et al. Cardiometabolic correlates and heritability of fetuin-A, retinol-binding protein 4, and fatty-acid binding protein 4 in the Framingham Heart Study. J. Clin. Endocrinol. Metab. 2012 Oct;97(10):E1943-7
Kaess BM et al
2012/01/01
PubMed
57 Kanbay M et al. Fibroblast growth factor 23 and fetuin A are independent predictors for the coronary artery disease extent in mild chronic kidney disease. Clin J Am Soc Nephrol 2010 Oct;5(10):1780-6
Kanbay M et al
2010/01/01
PubMed
58 Khadir A et al. Fetuin-A levels are increased in the adipose tissue of diabetic obese humans but not in circulation. Lipids Health Dis 2018 Dec;17(1):291
Khadir A et al
2018/01/01
PubMed
59 Kralisch S et al. Regulation of the novel adipokines/ hepatokines fetuin A and fetuin B in gestational diabetes mellitus. Metab. Clin. Exp. 2017 03;68:88-94
Kralisch S et al
2017/01/01
PubMed
60 Liu X et al. Circulating alanine transaminase (ALT) and γ-glutamyl transferase (GGT), but not fetuin-A, are associated with metabolic risk factors, at baseline and at two-year follow-up: the prospective Cyprus Metabolism Study. Metab. Clin. Exp. 201
Liu X et al
2014/01/01
PubMed
61 Lorant DP et al. Fetuin-A levels are increased in patients with type 2 diabetes and peripheral arterial disease. Diabetes Care 2011 Jan;34(1):156-61
Lorant DP et al
2011/01/01
PubMed
62 Lorenzen JM et al. Fetuin, matrix-Gla protein and osteopontin in calcification of renal allografts. PLoS ONE 2012;7(12):e52039
Lorenzen JM et al
2012/01/01
PubMed
63 Mattinzoli D et al. FGF23 and Fetuin-A Interaction in the Liver and in the Circulation. Int. J. Biol. Sci. 2018;14(6):586-598
Mattinzoli D et al
2018/01/01
PubMed
64 McMorrow AM et al. Personalized Cardio-Metabolic Responses to an Anti-Inflammatory Nutrition Intervention in Obese Adolescents: A Randomized Controlled Crossover Trial. Mol Nutr Food Res 2018 05;62(10):e1701008
McMorrow AM et al
2018/01/01
PubMed
65 Oh S et al. High-Intensity Aerobic Exercise Improves Both Hepatic Fat Content and Stiffness in Sedentary Obese Men with Nonalcoholic Fatty Liver Disease. Sci Rep 2017 02;7:43029
Oh S et al
2017/01/01
PubMed
66 Ou HY et al. Both diabetes and fetuin-A are independently associated with increased risk of arterial stiffness. Clin. Chim. Acta 2015 May;445:133-8
Ou HY et al
2015/01/01
PubMed
67 Ou HY et al. Increased fetuin-A concentrations in impaired glucose tolerance with or without nonalcoholic fatty liver disease, but not impaired fasting glucose. J. Clin. Endocrinol. Metab. 2012 Dec;97(12):4717-23
Ou HY et al
2012/01/01
PubMed
68 Park J et al. Discovery of the serum biomarker proteins in severe preeclampsia by proteomic analysis. Exp. Mol. Med. 2011 Jul;43(7):427-35
Park J et al
2011/01/01
PubMed
69 Reinehr T et al. Fibroblast Growth Factor 21 and Fetuin-A in Obese Adolescents With and Without Type 2 Diabetes. J. Clin. Endocrinol. Metab. 2015 Aug;100(8):3004-10
Reinehr T et al
2015/01/01
PubMed
70 Sak S et al. Associations of serum fetuin-A and oxidative stress parameters with polycystic ovary syndrome. Clin Exp Reprod Med 2018 Sep;45(3):116-121
Sak S et al
2018/01/01
PubMed
71 Smith ER et al. Serum fetuin-A concentration and fetuin-A-containing calciprotein particles in patients with chronic inflammatory disease and renal failure. Nephrology (Carlton) 2013 Mar;18(3):215-21
Smith ER et al
2013/01/01
PubMed
72 Tseng FY et al. Serum levels of fetuin-A are negatively associated with log transformation levels of thyroid-stimulating hormone in patients with hyperthyroidism or euthyroidism: An observational study at a medical center in Taiwan. Medicine (Baltimore) 2
Tseng FY et al
2018/01/01
PubMed
73 von Jeinsen B et al. Association of Circulating Adipokines With Echocardiographic Measures of Cardiac Structure and Function in a Community-Based Cohort. J Am Heart Assoc 2018 Jun;7(13)
von Jeinsen B et al
2018/01/01
PubMed
74 Wilund KR et al. Intradialytic exercise training reduces oxidative stress and epicardial fat: a pilot study. Nephrol Dial Transplant 2010 Aug;25(8):2695-701
Wilund KR et al
2010/01/01
PubMed
75 Wu HT et al. A novel hepatokine, HFREP1, plays a crucial role in the development of insulin resistance and type 2 diabetes. Diabetologia 2016 Aug;59(8):1732-42
Wu HT et al
2016/01/01
PubMed
76 Yang SJ et al. Effects of a three-month combined exercise programme on fibroblast growth factor 21 and fetuin-A levels and arterial stiffness in obese women. Clin Endocrinol (Oxf) 2011 Oct;75(4):464-9
Yang SJ et al
2011/01/01
PubMed
77 Yu CJ et al. Comprehensive proteome analysis of malignant pleural effusion for lung cancer biomarker discovery by using multidimensional protein identification technology. J Proteome Res 2011 Oct;10(10):4671-82
Yu CJ et al
2011/01/01
PubMed
78 Zhou ZW et al. Serum fetuin-A levels are independently correlated with vascular endothelial growth factor and C-reactive protein concentrations in type 2 diabetic patients with diabetic retinopathy. Clin Chim Acta 2016 Apr;455:113-7
Zhou ZW et al
2016/01/01
PubMed
79 Uygun ZO et al. Fullerene-PAMAM(G5) composite modified impedimetric biosensor to detect Fetuin-A in real blood samples. Anal Biochem 2018 Feb;542:11-15
Uygun ZO et al
2018/01/01
PubMed
80 Bielesz B et al. Calcification Propensity of Serum is Independent of Excretory Renal Function. Sci Rep 2017 12;7(1):17941
Bielesz B et al
2017/01/01
PubMed
81 Kr旦ger J et al. Circulating Fetuin-A and Risk of Type 2 Diabetes: A Mendelian Randomization Analysis. Diabetes 2018 06;67(6):1200-1205
Kr旦ger J et al
2018/01/01
PubMed
82 Shim YS et al. Fetuin-A as an Alternative Marker for Insulin Resistance and Cardiovascular Risk in Prepubertal Children. J Atheroscler Thromb 2017 Oct;24(10):1031-1038
Shim YS et al
2017/01/01
PubMed
83 Zachariah JP et al. Prospective Relation of Circulating Adipokines to Incident Metabolic Syndrome: The Framingham Heart Study. J Am Heart Assoc 2017 Jul;6(7)
Zachariah JP et al
2017/01/01
PubMed
84 Manco M et al. Arterial Stiffness, Thickness and Association to Suitable Novel Markers of Risk at the Origin of Cardiovascular Disease in Obese Children. Int J Med Sci 2017;14(8):711-720
Manco M et al
2017/01/01
PubMed
85 Otten J et al. A heterogeneous response of liver and skeletal muscle fat to the combination of a Paleolithic diet and exercise in obese individuals with type 2 diabetes: a randomised controlled trial. Diabetologia 2018 Jul;61(7):1548-1559
Otten J et al
2018/01/01
PubMed
86 M叩rkus B et al. Serum fetuin-A, tumor necrosis factor alpha and C-reactive protein concentrations in patients with hereditary angioedema with C1-inhibitor deficiency. Orphanet J Rare Dis 2019 Mar;14(1):67
M叩rkus B et al
2019/01/01
PubMed
87 Lee SM et al. Abdominal aortic calcification score among several vascular calcification scores of plain radiograph is the most reliable predictor of severe coronary artery calcification in dialysis patients. Ren Fail 2017 Nov;39(1):729-735
Lee SM et al
2017/01/01
PubMed
88 Diederichs T et al. Carbohydrates from Sources with a Higher Glycemic Index during Adolescence: Is Evening Rather than Morning Intake Relevant for Risk Markers of Type 2 Diabetes in Young Adulthood? Nutrients 2017 Jun;9(6)
Diederichs T et al
2017/01/01
PubMed
89 Jensen MK et al. Detection of genetic loci associated with plasma fetuin-A: a meta-analysis of genome-wide association studies from the CHARGE Consortium. Hum Mol Genet 2017 Jun;26(11):2156-2163
Jensen MK et al
2017/01/01
PubMed
90 Deト殃rmencioト殕u H et al. Presepsin and fetuin-A dyad for the diagnosis of proven sepsis in preterm neonates. BMC Infect Dis 2019 Aug;19(1):695
Deト殃rmencioト殕u H et al
2019/01/01
PubMed
91 Ozgu-Erdinc AS et al. There is No Association between Premature Ovarian Insufficiency and Levels of Fetuin-A/α2-Heremans-Schmid Glycoprotein. J Hum Reprod Sci 2019;12(4):299-302
Ozgu-Erdinc AS et al
2019/01/01
PubMed
92 Filardi T et al. Circulating levels of fetuin-A are associated with moderate-severe hepatic steatosis in young adults. J Endocrinol Invest 2021 Jan;44(1):105-110
Filardi T et al
2021/01/01
PubMed
93 Nakamura K et al. The effect of lanthanum carbonate on calciprotein particles in hemodialysis patients. Clin Exp Nephrol 2020 Apr;24(4):323-329
Nakamura K et al
2020/01/01
PubMed
  • No.: 1
  • 文献情報:
    Mori K et al. Association of serum fetuin-A with insulin resistance in type 2 diabetic and nondiabetic subjects. Diabetes Care 2006 Feb;29(2):468
    Mori K et al
    2006/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Jung HH et al. Inflammation, mineral metabolism and progressive coronary artery calcification in patients on haemodialysis. Nephrol. Dial. Transplant. 2006 Jul;21(7):1915-20
    Jung HH et al
    2006/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Stefan N et al. Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care 2006 Apr;29(4):853-7
    Stefan N et al
    2006/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    ZiテウナLowska H et al. [Fetuin A in children with renal diseases]. Prz. Lek. 2006;63 Suppl 3:54-6
    ZiテウナLowska H et al
    2006/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Mori K et al. Association of serum fetuin-A with carotid arterial stiffness. Clin. Endocrinol. (Oxf) 2007 Feb;66(2):246-50
    Mori K et al
    2007/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Caglar K et al. Endothelial dysfunction and fetuin A levels before and after kidney transplantation. Transplantation 2007 Feb;83(4):392-7
    Caglar K et al
    2007/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Kaden JJ et al. Systemic and local levels of fetuin-A in calcific aortic valve stenosis. Int. J. Mol. Med. 2007 Aug;20(2):193-7
    Kaden JJ et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Eller P et al. Impact of ENPP1 genotype on arterial calcification in patients with end-stage renal failure. Nephrol. Dial. Transplant. 2008 Jan;23(1):321-7
    Eller P et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Sigrist MK et al. Progressive vascular calcification over 2 years is associated with arterial stiffening and increased mortality in patients with stages 4 and 5 chronic kidney disease. Clin J Am Soc Nephrol 2007 Nov;2(6):1241-8
    Sigrist MK et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Caglar K et al. Short-term treatment with sevelamer increases serum fetuin-a concentration and improves endothelial dysfunction in chronic kidney disease stage 4 patients. Clin J Am Soc Nephrol 2008 Jan;3(1):61-8
    Caglar K et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Oikawa O et al. Evaluation of serum fetuin-A relationships with biochemical parameters in patients on hemodialysis. Clin. Exp. Nephrol. 2007 Dec;11(4):304-8
    Oikawa O et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Yilmaz MI et al. Endothelial dysfunction in type-2 diabetics with early diabetic nephropathy is associated with low circulating adiponectin. Nephrol. Dial. Transplant. 2008 May;23(5):1621-7
    Yilmaz MI et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Stejskal D et al. Urine fetuin-A values in relation to the presence of urolithiasis. BJU Int. 2008 May;101(9):1151-4
    Stejskal D et al
    2008/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Ziolkowska H et al. Determinants of the intima-media thickness in children and adolescents with chronic kidney disease. Pediatr. Nephrol. 2008 May;23(5):805-11
    Ziolkowska H et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Petrik V et al. Serum alpha 2-HS glycoprotein predicts survival in patients with glioblastoma. Clin. Chem. 2008 Apr;54(4):713-22
    Petrik V et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Caglar K et al. Serum fetuin-a concentration and endothelial dysfunction in chronic kidney disease. Nephron Clin Pract 2008;108(3):c233-40
    Caglar K et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Hennige AM et al. Fetuin-A induces cytokine expression and suppresses adiponectin production. PLoS ONE 2008;3(3):e1765
    Hennige AM et al
    2008/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Stefan N et al. Plasma fetuin-A levels and the risk of type 2 diabetes. Diabetes 2008 Oct;57(10):2762-7
    Stefan N et al
    2008/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Reinehr T et al. Fetuin-A and its relation to metabolic syndrome and fatty liver disease in obese children before and after weight loss. J. Clin. Endocrinol. Metab. 2008 Nov;93(11):4479-85
    Reinehr T et al
    2008/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Dervisoglu E et al. Serum fetuin--a concentrations are inversely related to cytokine concentrations in patients with chronic renal failure. Cytokine 2008 Dec;44(3):323-7
    Dervisoglu E et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Pańczyk-Tomaszewska M et al. [Fetuin A in children with nephrotic syndrome]. Pol. Merkur. Lekarski 2008;24 Suppl 4:65-7
    Pańczyk-Tomaszewska M et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    Weikert C et al. Plasma fetuin-a levels and the risk of myocardial infarction and ischemic stroke. Circulation 2008 Dec;118(24):2555-62
    Weikert C et al
    2008/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma
  • 参照:
    PubMed
  • No.: 23
  • 文献情報:
    Briana DD et al. Serum fetuin-A/alpha2-HS-glycoprotein in human pregnancies with normal and restricted fetal growth. J. Matern. Fetal. Neonatal. Med. 2008 Nov;21(11):826-30
    Briana DD et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 24
  • 文献情報:
    Roos M et al. Fetuin-A and arterial stiffness in patients with normal kidney function. Regul. Pept. 2009 Apr;154(1-3):39-43
    Roos M et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 25
  • 文献情報:
    Pertosa G et al. Serum fetuin a in hemodialysis: a link between derangement of calcium-phosphorus homeostasis and progression of atherosclerosis? Am. J. Kidney Dis. 2009 Mar;53(3):467-74
    Pertosa G et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 26
  • 文献情報:
    Bl叩ha V et al. Circulating fetuin-A predicts early mortality in chronic hemodialysis patients. Clin. Biochem. 2009 Jul;42(10-11):996-1000
    Bl叩ha V et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 27
  • 文献情報:
    Tumani H et al. CSF proteome analysis in clinically isolated syndrome (CIS): candidate markers for conversion to definite multiple sclerosis. Neurosci. Lett. 2009 Mar;452(2):214-7
    Tumani H et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 28
  • 文献情報:
    Katayama H et al. Application of serum proteomics to the Women"s Health Initiative conjugated equine estrogens trial reveals a multitude of effects relevant to clinical findings. Genome Med 2009;1(4):47
    Katayama H et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 29
  • 文献情報:
    Kaushik SV et al. Extended-release niacin decreases serum fetuin-A concentrations in individuals with metabolic syndrome. Diabetes Metab. Res. Rev. 2009 Jul;25(5):427-34
    Kaushik SV et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 30
  • 文献情報:
    Sigrist MK et al. Elevated osteoprotegerin is associated with all-cause mortality in CKD stage 4 and 5 patients in addition to vascular calcification. Nephrol. Dial. Transplant. 2009 Oct;24(10):3157-62
    Sigrist MK et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 31
  • 文献情報:
    Urbanov叩 M et al. Fetuin-A early after renal transplantation. Kidney Blood Press. Res. 2009;32(3):217-22
    Urbanov叩 M et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 32
  • 文献情報:
    Cianciolo G et al. Coronary calcifications in end-stage renal disease patients: a new link between osteoprotegerin, diabetes and body mass index? Blood Purif. 2010;29(1):13-22
    Cianciolo G et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 33
  • 文献情報:
    Brettschneider J et al. Proteome analysis reveals candidate markers of disease progression in amyotrophic lateral sclerosis (ALS). Neurosci. Lett. 2010 Jan;468(1):23-7
    Brettschneider J et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 34
  • 文献情報:
    Emoto M et al. Fetuin-A and atherosclerotic calcified plaque in patients with type 2 diabetes mellitus. Metab. Clin. Exp. 2010 Jun;59(6):873-8
    Emoto M et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 35
  • 文献情報:
    Uz O et al. The relationship between coronary calcification and the metabolic markers of osteopontin, fetuin-A, and visfatin. Turk Kardiyol Dern Ars 2009 Sep;37(6):397-402
    Uz O et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 36
  • 文献情報:
    Ford ML et al. Fetuin-A is an independent determinant of change of aortic stiffness over 1 year in non-diabetic patients with CKD stages 3 and 4. Nephrol. Dial. Transplant. 2010 Jun;25(6):1853-8
    Ford ML et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 37
  • 文献情報:
    Smith ER et al. Poor agreement between commercial ELISAs for plasma fetuin-A: An effect of protein glycosylation? Clin. Chim. Acta 2010 Sep;411(17-18):1367-70
    Smith ER et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 38
  • 文献情報:
    Kl旦ting N et al. Insulin-sensitive obesity. Am. J. Physiol. Endocrinol. Metab. 2010 Sep;299(3):E506-15
    Kl旦ting N et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 39
  • 文献情報:
    Kuナ嬾ierz-Cabala B et al. Serum fetuin A concentrations in patients with acute pancreatitis. Clin. Lab. 2010;56(5-6):191-5
    Kuナ嬾ierz-Cabala B et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 40
  • 文献情報:
    Brix JM et al. Elevated Fetuin-A concentrations in morbid obesity decrease after dramatic weight loss. J. Clin. Endocrinol. Metab. 2010 Nov;95(11):4877-81
    Brix JM et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 41
  • 文献情報:
    T旦njes A et al. Adipokine pattern in subjects with impaired fasting glucose and impaired glucose tolerance in comparison to normal glucose tolerance and diabetes. PLoS ONE 2010;5(11):e13911
    T旦njes A et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 42
  • 文献情報:
    Cutler P et al. Proteomic identification and early validation of complement 1 inhibitor and pigment epithelium-derived factor: Two novel biomarkers of Alzheimer"s disease in human plasma. Proteomics Clin Appl 2008 Apr;2(4):467-77
    Cutler P et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 43
  • 文献情報:
    Abali R et al. The serum protein α2-Heremans-Schmid glycoprotein/fetuin-a concentration and carotid intima-media thickness in women with polycystic ovary syndrome. Eur. J. Obstet. Gynecol. Reprod. Biol. 2013 Jul;169(1):45-9
    Abali R et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 44
  • 文献情報:
    Aleksandrova K et al. Circulating Omentin as a Novel Biomarker for Colorectal Cancer Risk: Data from the EPIC-Potsdam Cohort Study. Cancer Res. 2016 07;76(13):3862-71
    Aleksandrova K et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 45
  • 文献情報:
    Argani H et al. Serum Fetuin-A and Pentraxin3 in hemodialysis and renal transplant patients. Clin. Biochem. 2012 Jul;45(10-11):775-9
    Argani H et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 46
  • 文献情報:
    Bakiner O et al. Plasma fetuin-A levels are reduced in patients with hypothyroidism. Eur. J. Endocrinol. 2014 Mar;170(3):411-8
    Bakiner O et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 47
  • 文献情報:
    Cagli K et al. Association of serum fetuin-A with valvular calcium concentration in rheumatic mitral valve disease. J. Heart Valve Dis. 2010 Sep;19(5):636-43
    Cagli K et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 48
  • 文献情報:
    Chang WT et al. Serum vitamin D, intact parathyroid hormone, and Fetuin A concentrations were associated with geriatric sarcopenia and cardiac hypertrophy. Sci Rep 2017 01;7:40996
    Chang WT et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 49
  • 文献情報:
    Dalamaga M et al. Higher fetuin-A, lower adiponectin and free leptin levels mediate effects of excess body weight on insulin resistance and risk for myelodysplastic syndrome. Metab. Clin. Exp. 2013 Dec;62(12):1830-9
    Dalamaga M et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 50
  • 文献情報:
    Eraso LH et al. Association of lower plasma fetuin-a levels with peripheral arterial disease in type 2 diabetes. Diabetes Care 2010 Feb;33(2):408-10
    Eraso LH et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 51
  • 文献情報:
    Hamano T et al. Fetuin-mineral complex reflects extraosseous calcification stress in CKD. J. Am. Soc. Nephrol. 2010 Nov;21(11):1998-2007
    Hamano T et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 52
  • 文献情報:
    Harris VK et al. Cerebrospinal fluid fetuin-A is a biomarker of active multiple sclerosis. Mult. Scler. 2013 Feb;
    Harris VK et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 53
  • 文献情報:
    Hwang JJ et al. Circulating fetuin-A levels are not affected by short and long-term energy deprivation and/or by leptin administration. Metab. Clin. Exp. 2014 Jun;63(6):754-9
    Hwang JJ et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 54
  • 文献情報:
    Ishibashi A et al. Serum fetuin-A is an independent marker of insulin resistance in Japanese men. J. Atheroscler. Thromb. 2010 Sep;17(9):925-33
    Ishibashi A et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 55
  • 文献情報:
    Jim辿nez MC et al. Circulating fetuin-A and risk of ischemic stroke in women. Clin. Chem. 2014 Jan;60(1):165-73
    Jim辿nez MC et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 56
  • 文献情報:
    Kaess BM et al. Cardiometabolic correlates and heritability of fetuin-A, retinol-binding protein 4, and fatty-acid binding protein 4 in the Framingham Heart Study. J. Clin. Endocrinol. Metab. 2012 Oct;97(10):E1943-7
    Kaess BM et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 57
  • 文献情報:
    Kanbay M et al. Fibroblast growth factor 23 and fetuin A are independent predictors for the coronary artery disease extent in mild chronic kidney disease. Clin J Am Soc Nephrol 2010 Oct;5(10):1780-6
    Kanbay M et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 58
  • 文献情報:
    Khadir A et al. Fetuin-A levels are increased in the adipose tissue of diabetic obese humans but not in circulation. Lipids Health Dis 2018 Dec;17(1):291
    Khadir A et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 59
  • 文献情報:
    Kralisch S et al. Regulation of the novel adipokines/ hepatokines fetuin A and fetuin B in gestational diabetes mellitus. Metab. Clin. Exp. 2017 03;68:88-94
    Kralisch S et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 60
  • 文献情報:
    Liu X et al. Circulating alanine transaminase (ALT) and γ-glutamyl transferase (GGT), but not fetuin-A, are associated with metabolic risk factors, at baseline and at two-year follow-up: the prospective Cyprus Metabolism Study. Metab. Clin. Exp. 201
    Liu X et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 61
  • 文献情報:
    Lorant DP et al. Fetuin-A levels are increased in patients with type 2 diabetes and peripheral arterial disease. Diabetes Care 2011 Jan;34(1):156-61
    Lorant DP et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 62
  • 文献情報:
    Lorenzen JM et al. Fetuin, matrix-Gla protein and osteopontin in calcification of renal allografts. PLoS ONE 2012;7(12):e52039
    Lorenzen JM et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 63
  • 文献情報:
    Mattinzoli D et al. FGF23 and Fetuin-A Interaction in the Liver and in the Circulation. Int. J. Biol. Sci. 2018;14(6):586-598
    Mattinzoli D et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 64
  • 文献情報:
    McMorrow AM et al. Personalized Cardio-Metabolic Responses to an Anti-Inflammatory Nutrition Intervention in Obese Adolescents: A Randomized Controlled Crossover Trial. Mol Nutr Food Res 2018 05;62(10):e1701008
    McMorrow AM et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 65
  • 文献情報:
    Oh S et al. High-Intensity Aerobic Exercise Improves Both Hepatic Fat Content and Stiffness in Sedentary Obese Men with Nonalcoholic Fatty Liver Disease. Sci Rep 2017 02;7:43029
    Oh S et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 66
  • 文献情報:
    Ou HY et al. Both diabetes and fetuin-A are independently associated with increased risk of arterial stiffness. Clin. Chim. Acta 2015 May;445:133-8
    Ou HY et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 67
  • 文献情報:
    Ou HY et al. Increased fetuin-A concentrations in impaired glucose tolerance with or without nonalcoholic fatty liver disease, but not impaired fasting glucose. J. Clin. Endocrinol. Metab. 2012 Dec;97(12):4717-23
    Ou HY et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 68
  • 文献情報:
    Park J et al. Discovery of the serum biomarker proteins in severe preeclampsia by proteomic analysis. Exp. Mol. Med. 2011 Jul;43(7):427-35
    Park J et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 69
  • 文献情報:
    Reinehr T et al. Fibroblast Growth Factor 21 and Fetuin-A in Obese Adolescents With and Without Type 2 Diabetes. J. Clin. Endocrinol. Metab. 2015 Aug;100(8):3004-10
    Reinehr T et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 70
  • 文献情報:
    Sak S et al. Associations of serum fetuin-A and oxidative stress parameters with polycystic ovary syndrome. Clin Exp Reprod Med 2018 Sep;45(3):116-121
    Sak S et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 71
  • 文献情報:
    Smith ER et al. Serum fetuin-A concentration and fetuin-A-containing calciprotein particles in patients with chronic inflammatory disease and renal failure. Nephrology (Carlton) 2013 Mar;18(3):215-21
    Smith ER et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 72
  • 文献情報:
    Tseng FY et al. Serum levels of fetuin-A are negatively associated with log transformation levels of thyroid-stimulating hormone in patients with hyperthyroidism or euthyroidism: An observational study at a medical center in Taiwan. Medicine (Baltimore) 2
    Tseng FY et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 73
  • 文献情報:
    von Jeinsen B et al. Association of Circulating Adipokines With Echocardiographic Measures of Cardiac Structure and Function in a Community-Based Cohort. J Am Heart Assoc 2018 Jun;7(13)
    von Jeinsen B et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 74
  • 文献情報:
    Wilund KR et al. Intradialytic exercise training reduces oxidative stress and epicardial fat: a pilot study. Nephrol Dial Transplant 2010 Aug;25(8):2695-701
    Wilund KR et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 75
  • 文献情報:
    Wu HT et al. A novel hepatokine, HFREP1, plays a crucial role in the development of insulin resistance and type 2 diabetes. Diabetologia 2016 Aug;59(8):1732-42
    Wu HT et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 76
  • 文献情報:
    Yang SJ et al. Effects of a three-month combined exercise programme on fibroblast growth factor 21 and fetuin-A levels and arterial stiffness in obese women. Clin Endocrinol (Oxf) 2011 Oct;75(4):464-9
    Yang SJ et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 77
  • 文献情報:
    Yu CJ et al. Comprehensive proteome analysis of malignant pleural effusion for lung cancer biomarker discovery by using multidimensional protein identification technology. J Proteome Res 2011 Oct;10(10):4671-82
    Yu CJ et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 78
  • 文献情報:
    Zhou ZW et al. Serum fetuin-A levels are independently correlated with vascular endothelial growth factor and C-reactive protein concentrations in type 2 diabetic patients with diabetic retinopathy. Clin Chim Acta 2016 Apr;455:113-7
    Zhou ZW et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 79
  • 文献情報:
    Uygun ZO et al. Fullerene-PAMAM(G5) composite modified impedimetric biosensor to detect Fetuin-A in real blood samples. Anal Biochem 2018 Feb;542:11-15
    Uygun ZO et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 80
  • 文献情報:
    Bielesz B et al. Calcification Propensity of Serum is Independent of Excretory Renal Function. Sci Rep 2017 12;7(1):17941
    Bielesz B et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 81
  • 文献情報:
    Kr旦ger J et al. Circulating Fetuin-A and Risk of Type 2 Diabetes: A Mendelian Randomization Analysis. Diabetes 2018 06;67(6):1200-1205
    Kr旦ger J et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 82
  • 文献情報:
    Shim YS et al. Fetuin-A as an Alternative Marker for Insulin Resistance and Cardiovascular Risk in Prepubertal Children. J Atheroscler Thromb 2017 Oct;24(10):1031-1038
    Shim YS et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 83
  • 文献情報:
    Zachariah JP et al. Prospective Relation of Circulating Adipokines to Incident Metabolic Syndrome: The Framingham Heart Study. J Am Heart Assoc 2017 Jul;6(7)
    Zachariah JP et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 84
  • 文献情報:
    Manco M et al. Arterial Stiffness, Thickness and Association to Suitable Novel Markers of Risk at the Origin of Cardiovascular Disease in Obese Children. Int J Med Sci 2017;14(8):711-720
    Manco M et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 85
  • 文献情報:
    Otten J et al. A heterogeneous response of liver and skeletal muscle fat to the combination of a Paleolithic diet and exercise in obese individuals with type 2 diabetes: a randomised controlled trial. Diabetologia 2018 Jul;61(7):1548-1559
    Otten J et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 86
  • 文献情報:
    M叩rkus B et al. Serum fetuin-A, tumor necrosis factor alpha and C-reactive protein concentrations in patients with hereditary angioedema with C1-inhibitor deficiency. Orphanet J Rare Dis 2019 Mar;14(1):67
    M叩rkus B et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 87
  • 文献情報:
    Lee SM et al. Abdominal aortic calcification score among several vascular calcification scores of plain radiograph is the most reliable predictor of severe coronary artery calcification in dialysis patients. Ren Fail 2017 Nov;39(1):729-735
    Lee SM et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 88
  • 文献情報:
    Diederichs T et al. Carbohydrates from Sources with a Higher Glycemic Index during Adolescence: Is Evening Rather than Morning Intake Relevant for Risk Markers of Type 2 Diabetes in Young Adulthood? Nutrients 2017 Jun;9(6)
    Diederichs T et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 89
  • 文献情報:
    Jensen MK et al. Detection of genetic loci associated with plasma fetuin-A: a meta-analysis of genome-wide association studies from the CHARGE Consortium. Hum Mol Genet 2017 Jun;26(11):2156-2163
    Jensen MK et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 90
  • 文献情報:
    Deト殃rmencioト殕u H et al. Presepsin and fetuin-A dyad for the diagnosis of proven sepsis in preterm neonates. BMC Infect Dis 2019 Aug;19(1):695
    Deト殃rmencioト殕u H et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 91
  • 文献情報:
    Ozgu-Erdinc AS et al. There is No Association between Premature Ovarian Insufficiency and Levels of Fetuin-A/α2-Heremans-Schmid Glycoprotein. J Hum Reprod Sci 2019;12(4):299-302
    Ozgu-Erdinc AS et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 92
  • 文献情報:
    Filardi T et al. Circulating levels of fetuin-A are associated with moderate-severe hepatic steatosis in young adults. J Endocrinol Invest 2021 Jan;44(1):105-110
    Filardi T et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 93
  • 文献情報:
    Nakamura K et al. The effect of lanthanum carbonate on calciprotein particles in hemodialysis patients. Clin Exp Nephrol 2020 Apr;24(4):323-329
    Nakamura K et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed